Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPharmacy & Specialty DrugsUnitedHealthcare Mulpleta Coverage | OpenPayer
    Ask Trek AI about this page
    CurrentUnitedHealthcarePolicy N/A

    Mulpleta (lusutrombopag) Coverage

    Customize your policy alerts

    Sign up for all UnitedHealthcare policy alerts

    Know when UnitedHealthcare releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs prior authorization and medical-necessity coverage for Mulpleta (lusutrombopag) in adults with thrombocytopenia associated with chronic liver disease who are scheduled to undergo a procedure. Approval requires specified clinical criteria, including failure, contraindication, or intolerance to Doptelet (avatrombopag).

    Policy Summary
    PayerUnitedHealthcare
    PolicyMulpleta (lusutrombopag) Coverage
    Policy CodePolicy N/A
    Change TypeAnnual reviewno clinical or coverage change
    Effective DateOctober 1, 2026
    Last ReviewJul 1, 2026
    Next Review DateN/A
    Key ActionSubmit documentation supporting thrombocytopenia, chronic liver disease, the scheduled procedure, and failure, contraindication, or intolerance to Doptelet before requesting authorization.
    SourceLink
    POLICY UPDATE CHANGES

    The annual review reported no change to the coverage criteria and updated the reference information.

    1 monthAuthorization duration
    4Required coverage criteria
    DopteletRequired prior therapy
    Adult thrombocytopeniaCovered indication

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Coverage Criteria

    Thrombocytopenia

    Mulpleta will be approved when all of the following are met:

    All coverage criteria

    • Clinical and treatment requirements

      • Diagnosis: Patient has a diagnosis of thrombocytopenia
      • Underlying condition: Patient has chronic liver disease
      • Planned procedure: Patient is scheduled to undergo a procedure
      • Prior Doptelet therapy: Patient has a history of failure, contraindication, or intolerance to Doptelet (avatrombopag)

    Initial Mulpleta Authorization

    Initial Mulpleta authorization

    Initial approval requires all of the following criteria:

    Initial therapy requirements

    • Thrombocytopenia: Patient has a diagnosis of thrombocytopenia
    • Chronic liver disease: Patient has chronic liver disease
    • Scheduled procedure: Patient is scheduled to undergo a procedure
    • Doptelet history: Patient has a history of failure, contraindication, or intolerance to Doptelet (avatrombopag)

    Required Prior Therapy

    StepRequirementCoverage impact
    1History of failure, contraindication, or intolerance to Doptelet (avatrombopag) before Mulpleta approvalRequired for Mulpleta approval

    Provider Actions and Authorization Requirements

    Prior Authorization

    Prior Authorization Required

    Submit the request for prior authorization and medical-necessity review. Mulpleta approval requires all four coverage criteria to be documented, and authorization is issued for 1 month.

    • Diagnosis of thrombocytopenia
    • Chronic liver disease
    • Scheduled procedure
    • History of failure, contraindication, or intolerance to Doptelet (avatrombopag)
    Step Therapy

    Doptelet Prerequisite

    Before Mulpleta approval, document that the patient has failed, is contraindicated for, or is intolerant to Doptelet (avatrombopag).

    Medication Definition

    Definitions
    MedicationMulpleta (lusutrombopag)
    Drug classThrombopoietin receptor agonist
    Indicated populationAdult patients with thrombocytopenia associated with chronic liver disease who are scheduled to undergo a procedure

    Authorization Duration

    Quantity Limits
    MedicationMulpleta (lusutrombopag)
    Authorization duration1 month
    Authorization basisIssued when all coverage criteria are met
    Policy Summary
    PayerUnitedHealthcare
    PolicyMulpleta (lusutrombopag) Coverage
    Policy CodePolicy N/A
    Change TypeAnnual reviewno clinical or coverage change
    Effective DateOctober 1, 2026
    Last ReviewJul 1, 2026
    Next Review DateN/A
    Key ActionSubmit documentation supporting thrombocytopenia, chronic liver disease, the scheduled procedure, and failure, contraindication, or intolerance to Doptelet before requesting authorization.
    SourceLink
    On This Page
    Coverage CriteriaInitial Mulpleta AuthorizationRequired Prior TherapyProvider Actions and Authorization RequirementsBackgroundMedication DefinitionAuthorization Duration
    Documentation Required

    Clinical Documentation Required

    Provide clinical documentation supporting the diagnosis of thrombocytopenia, chronic liver disease, the scheduled procedure, and the patient's relevant Doptelet treatment history, including failure, contraindication, or intolerance.

    Denial Risk

    Required Coverage Criteria Not Met

    Coverage may be denied when the required diagnosis, chronic liver disease, scheduled procedure, or documented failure, contraindication, or intolerance to Doptelet is absent. Authorization is limited to 1 month when approved.